FDA-Device2026-06-17Class IIPROCESSING DEFECT
InspireMD CGuard Prime Carotid Stent System recalled for deployment complications
OTHERNationwide distribution
InspireMD CGuard Prime stent recalled for deployment risk
The CGuard Prime Carotid Stent System (model CND0840, 8mm×40mm) may experience high resistance or fail to deploy properly during the placement procedure. This affects 424 units manufactured between early February 2025 and February 2026.
- If you received this stent or are scheduled to receive one, contact your healthcare provider immediately.
- Do not proceed with stent placement using an affected unit without consulting your doctor.
- Contact InspireMD for information on replacement or alternative options.
Hazard
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Sold states
US Nationwide distribution in the states of AR, AZ, CA, DC, FL, GA, HI, IL, IN, KS, MA, MD, MI, MO, NC, NJ, NV, NY, OH, OR, RI, SD, TN, TX, VA, WA, WI, WV.
Affected count
424 units
Manufactured in
6303 Waterford District Dr Ste 215, N/A, Miami, FL, United States
Products
Brand Name: CGuard¿ Prime Carotid Stent System, 135cm, 8mmx40mm Model/Catalog Number: CND0840
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2326-2026More INSPIREMD Inc recalls
- FDA-Device2026-06-17InspireMD CGuard Prime Carotid Stent System recalled for deployment complications
- FDA-Device2026-06-17InspireMD CGuard Prime Carotid Stent System recalled for deployment complications
- FDA-Device2026-06-17INSPIREMD CGuard Prime Carotid Stent System recalled for deployment complications
- FDA-Device2026-06-17InspireMD CGuard Prime Carotid Stent System recalled for deployment complications
- FDA-Device2026-06-17InspireMD CGuard Prime Carotid Stent System recalled for deployment complications
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief